About Us
Bringing Health Equity in Precision Medicine Through Affordable Molecular Diagnostics
The Future of Affordable Testing is Here!
Pathgen Diagnostik Teknologi distinguishes itself through its use of cutting edge technologies in biomolecular sciences, including multiomics analysis, clustered regularly interspaced short palindromic repeats (CRISPR), and digital pathology. These technological advancements enable the company to leapfrog in innovation and acceleration of product discoveries.
Pathgen Diagnostik Teknology is an innovative healthcare company with a focus on bringing health equity in precision medicine. The company is committed to providing low-cost molecular diagnostics for non-communicable diseases, especially in the oncology sector, and engaging in capacity building through global knowledge exchange.
Vision
“Democratizing genomics solutions in lower & middle – income countries”
Mission
“Providing low –cost molecular diagnostics for cancer and other diseases in Indonesia and engaging in capacity building through knowledge exchange with the global partners.”
Awards
PathGen achieved remarkable milestones and garnered numerous accolades that testify to our dedication to
delivering the best solutions
Top 10 Winner of Health Innovation Sprint Accelerator by Indonesia Ministry of Health and East Ventures
Global Winner of People’s Choice Award of Extreme Tech Challenge 2021
First Winner of Impact Driven Business Competition held by Fortia Strategic Partner
Awards
PathGen achieved remarkable milestones and garnered numerous accolades that testify to our dedication to delivering the best solutions
Top 10 Winner of Health Innovation Sprint Accelerator by Indonesia Ministry of Health and East Ventures
Global Winner of People’s Choice Award of Extreme Tech Challenge 2021 as CEO/Founder of PathGen Diagnostik Teknologi
First Winner of Impact Driven Business Competition held by Fortia Strategic Partner
Our Partners
Strong Ecosystem, Makes Us Different
PathGen engages with a diverse range of stakeholders, including academics, government, businesses, and healthcare providers. This makes us a strong and reliable company.